Jun 7, 2011 – Biogen Idec received approval from the European Commission for its Avonex Pen for patients with relapsing multiple sclerosis (MS) and .

Jun 8, 2011 – Biogen Idec (BIIB) recently received EU approval for Avonex Pen, which is a single-use intramuscular auto-injector. .

Avonex Pen Biogen Idec Inc. said Tuesday that European Union regulators approved an injectable pen version of its multiple sclerosis drug Avonex. .

Jun 7, 2011 – Biogen Idec Inc. (BIIB) announced that the European .

Jun 7, 2011 – Avonex Pen (Avonex 30mcg/50ml solution for injection, in pre-filled pen) is a single-use, once-a-week, intramuscular autoinjector which .

Jun 7, 2011 – Biogen Idec (NASDAQ: BIIB) announced today that the European Commission ( EC) has granted approval to AVONEX PEN for patients with .

Jun 7, 2011 – Biogen Idec said it will start making the pens available in Europe over the next few weeks. Avonex is the Weston, Mass., company's biggest .

Jun 7, 2011 – Biogen Idec (NASDAQ: BIIB) announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing .

Jun 7, 2011 – Biogen Idec said it will start making the pens available in Europe over the next few weeks. Avonex is the Weston, Mass., company's biggest .

Jun 7, 2011 – Biogen Idec (NASDAQ: BIIB) ha annunciato oggi che la Commissione Europea ( CE) ha concesso l'approvazione per PEN AVONEX per i .

Jun 7, 2011 – ZUG, Switzerland--(BUSINESS WIRE)-- Biogen Idec (NASDAQ:BIIB - News) announced today that the.

Apr 19, 2011 – Biogen Idec has received positive opinion from the European .

Jun 7, 2011 – Biogen Idec (NASDAQ: BIIB) announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing .

Jun 7, 2011 – Biogen Idec designed AVONEX PEN to improve convenience of AVONEX administration by simplifying the injection, helping to reduce injection .

Jun 7, 2011 – Biogen Idec Inc. said Tuesday that European Union regulators approved an injectable pen version of its multiple sclerosis drug Avonex.

Jun 7, 2011 – Biogen Idec announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple .

Jun 2, 2011 – Biogen Idec Canada Inc announced AVONEX® PEN™ is now available for patients with relapsing multiple sclerosis (MS) and patients with a .

Jun 8, 2011 – Biogen Idec has received approval form the European Commission for AVONEX PEN to treat patients with relapsing multiple sclerosis, or MS, .

Jun 7, 2011 – Biogen Idec Inc. said Tuesday that European Union regulators approved an injectable pen version of its multiple sclerosis drug Avonex.

Jun 23, 2011 – Laboratory Equipment Eu Approval for Biogen's Avonex Pen Zacks.com Biogen Idec ( BIIB - Analyst Report) recently received Eu approval for .

Jun 7, 2011 – The European regulatory authorities approved Biogen Idec's single-use intramuscular autoinjector, Avonex PEN, for patients with relapsing .

Jun 7, 2011 – Biogen Idec Receives Approval in the European Union for AVONEX® PEN? European Commission approves the first single-use intramuscular .

Biogen Idec Says EU Regulators Approved Avonex Pen . Biogen Idec's 3rd-quarter profit falls on higher costs and expenses, acquisition charges .

Jun 8, 2011 – Biogen Idec (NASDAQ:BIIB) recently received EU approval for Avonex Pen, which is a single-use intramuscular auto-injector. Approval has .

Biogen Idec announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion .

Jun 7, 2011 – Biogen Idec Inc. said Tuesday that European Union regulators approved an injectable pen version of its multiple sclerosis drug Avonex.

Jun 7, 2011 – Biogen Idec announced today that the European Commission has granted approval to AVONEX PEN for patients with relapsing multiple .

Jun 7, 2011 – Biogen Idec (Nasdaq: BIIB) plans to launch Avonex Pen in countries across Europe in the coming weeks, and company officials say they are .

Apr 19, 2011 – Biogen Idec has offices in 29 countries around the world. .

Jun 7, 2011 – NEW YORK (AP) — Biogen Idec Inc. said Tuesday that European Union regulators approved an injectable pen version of its multiple sclerosis .

Jun 7, 2011 – Biogen Idec has obtained the European Commission's (EC) approval for Avonex Pen for patients who are suffering from relapsing multiple .

Biogen Idec Inc. announced that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and .

Jun 7, 2011 – Biogen Idec designed AVONEX PEN to improve convenience of AVONEX administration by simplifying the injection, helping to reduce injection .

Jun 8, 2011 – Biogen Idec says EU regulators approved Avonex pen. NEW YORK (AP) - Biogen Idec Inc. said Tuesday that European Union regulators approved an .

Jun 7, 2011 – BIIB Biogen Idec Biogen Idec Receives Approval in the European Union for AVONEX® PEN™

Jun 7, 2011 – Biogen Idec said it will start making the pens available in Europe over the next few weeks. Avonex is the Weston, Mass., company's biggest .

Jun 7, 2011 – Biogen Idec said it will start making the pens available in Europe over the next few weeks. Avonex is the Weston, Mass., company's biggest .

Nachricht: Biogen Idec Receives Approval in the European Union for AVONEX® PEN - 07.06.11 08:00.

Jun 7, 2011 – Biogen Idec announced Tuesday that the European Commission approved an injectable pen version of its multiple sclerosis therapy Avonex .

Jun 7, 2011 – Biogen Idec said it will start making the pens available in Europe over the next few weeks. Avonex is the Weston, Mass., company's biggest .

Jun 7, 2011 – Biogen Idecs Avonex Pen For MS Patients Gets European Approval.

Jun 7, 2011 – Biogen's Avonex Pen gets European OK. . Biogen Idec Inc. has won approval from the European Commission for its Avonex Pen to treat .

Jun 7, 2011 – Biogen Idec designed AVONEX PEN to improve convenience of AVONEX administration by simplifying the injection, helping to reduce injection .

Jun 7, 2011 – Biogen Idec has received European approval on an injectible pen that delivers the multiple sclerosis drug Avonex. Read more about what this .

Jun 8, 2011 – Biogen Idec Inc. said Tuesday that European Union regulators approved an injectable pen version of its multiple sclerosis drug Avonex. The.

Jun 7, 2011 – Biogen Idec hat den AVONEX PEN darauf ausgelegt, die Vergabe von AVONEX bequemer zu gestalten, indem er die Injektion vereinfacht, die .

Jun 7, 2011 – Biotechnology company Biogen Idec Inc. (BIIB) Tuesday stated that its avonex 30mcg/50ml solution for injection in pre-filled pen, known as .

Jun 8, 2011 – Biogen Idec announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple .

Jun 8, 2011 – Biogen Idec receives EU approval for Avonex Pen . Development at Biogen Idec , said: 'For more than 10 years, Avonex (interferon beta-1a) .

Biogen Idec Receives Approval in the European Union for Avonex Pen. From the PharmaLive.com News Archive - Jun. 07, 2011. European Commission .

Sitemap